Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score77
United States Fiscal year ends December CIK 0001368514 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
42,000
$12.00
$504.00K
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
105,000
$12.00
$1.26M

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 105,000
History held since 13 Feb 2012